DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Share Price

Certificat

DE000ME9LNB8

Market Closed - Börse Stuttgart 20:11:49 17/06/2024 BST
0.164 EUR -9.39% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS
Current month-53.14%
1 month-67.84%
Date Price Change
17/06/24 0.164 -9.39%
14/06/24 0.181 +1.12%
13/06/24 0.179 -3.24%
12/06/24 0.185 -8.87%
11/06/24 0.203 -10.96%

Delayed Quote Börse Stuttgart

Last update June 17, 2024 at 08:11 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN ME9LNB
ISINDE000ME9LNB8
Date issued 05/03/2024
Strike 85 $
Maturity 20/12/2024 (186 Days)
Parity 10 : 1
Emission price 0.31
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.52
Lowest since issue 0.151
Spread 0.008
Spread %4.79%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
58.42 USD
Average target price
87.55 USD
Spread / Average Target
+49.87%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW